Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: expert clinical opinion.

a Department of Medicine, University Hospital of Zürich, Zürich, Switzerland b Hospital Doctor Josep Trueta, Girona, Catalonia, Spain c Evangelisches Krankenhaus Kalk, Innere Medizin, University of Cologne, Germany d Department of Internal Medicine, Södra Älvsborgs Hospital, Borås, Sweden e Mittmann Pharma Consulting, Basel, Switzerland f Alimentary Pharmabiotic Centre, University College Cork, National University of Ireland, Cork, Ireland g Department of Gastroenterology, Inserm U954, University Hospital of Nancy, Henri Poincaré University, Vandœuvre-lès-Nancy, France h Department of Gastroenterology and Hepatology, CHUV/University Hospital Lausanne, Lausanne, Switzerland i University of Oslo, EpiGen, Campus Ahus and Section for Gastroenterology, Oslo University Hospital, Rikshospitalet, Oslo, Norway j Division of Gastroenterology and Hepatology, Triemli Hospital Zürich, Zürich, Switzerland k Kings College Hospital NHS Foundation Trust, Kings College Hospital, London, United Kingdom